Did not become law. It stopped in the House of Representatives's Revenue Committee on June 30, 2019. The 2019 session has ended.
2019 Regular Session
House Bill 3192
Imposes annual assessment on manufacture of prescription opioids.
What it does
The synopsis the Legislative Assembly published with the bill.
Imposes annual assessment on manufacture of prescription opioids. Applies to opioids dispensed on or after January 1, 2020. Takes effect on 91st day following adjournment sine die.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Its course
February 28 to June 30, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action6 actions on 5 days
In the House of RepresentativesFeb 28 to Jun 30 · stopped122 days
Waiting for a committeeFeb 28 to Mar 66 days
Health CareMar 6 to Mar 2620 days
RevenueMar 26 to Jun 30 · stopped96 days
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the House of Representatives Feb 28 – Jun 30
- Feb 28Introduced
- Mar 6Sent to Health Care
- Mar 21Heard in Health Care
- Mar 26Health Care reported it without a recommendation, and that it go to Revenue
- Sent to Revenue
- Jun 30Died when the session ended
All 6 actions, as published
- Feb 28First reading. Referred to Speaker's desk.House of Representatives
- Mar 6Referred to Health Care with subsequent referral to Revenue.House of Representatives
- Mar 21Work Session held.House of Representatives
- Mar 26Without recommendation as to passage and be referred to Revenue by prior reference.House of Representatives
- Mar 26Referred to Revenue by prior reference.House of Representatives
- Jun 30In committee upon adjournment.House of Representatives